Gold Reserve Ltd.
US ˙ OTCPK

Introduction

This page provides a comprehensive analysis of the known insider trading history of Eric Shahinian. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Eric Shahinian has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:GDRZF / Gold Reserve Ltd. 10% Owner 9,605,428
US:KTTA / Pasithea Therapeutics Corp. 1,788,415
US:LSYN / Liberated Syndication Inc Director 5,242,792
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Eric Shahinian. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases GDRZF / Gold Reserve Ltd. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in GDRZF / Gold Reserve Ltd.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2025-04-24 GDRZF Camac Capital, LLC 19,700 1.6000 19,700 1.6000 31,520 730
2025-04-07 GDRZF Camac Capital, LLC 10,000 1.6800 10,000 1.6800 16,800
2025-04-04 GDRZF Camac Capital, LLC 100 1.5500 100 1.5500 155
2025-04-03 GDRZF Camac Capital, LLC 22,375 1.6700 22,375 1.6700 37,366
2025-03-28 GDRZF Camac Capital, LLC 25,000 1.7600 25,000 1.7600 44,000
2025-03-27 GDRZF Camac Capital, LLC 12,000 1.8000 12,000 1.8000 21,600
2025-03-24 GDRZF Camac Capital, LLC 1,500 1,856.0000 1,500 1,856.0000 2,784,000
2025-03-21 GDRZF Camac Capital, LLC 100,000 2.1000 100,000 2.1000 210,000
2025-03-21 GDRZF Camac Capital, LLC 331,900 2.0747 331,900 2.0747 688,593
2025-03-13 GDRZF Camac Capital, LLC 14,000 2.0600 14,000 2.0600 28,840
2025-03-12 GDRZF Camac Capital, LLC 17,154 2.0500 17,154 2.0500 35,166
2025-03-10 GDRZF Camac Capital, LLC 383,401 1.9200 383,401 1.9200 736,130
2025-03-07 GDRZF Camac Capital, LLC 100 1.7000 100 1.7000 170
2025-03-06 GDRZF Camac Capital, LLC 27,376 1.7000 27,376 1.7000 46,539
2025-02-04 GDRZF Camac Capital, LLC 100,000 1.6200 100,000 1.6200 162,000
2025-01-22 GDRZF Camac Capital, LLC 56,700 1.4800 56,700 1.4800 83,916

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

GDRZF / Gold Reserve Ltd. Insider Trades
Insider Sales GDRZF / Gold Reserve Ltd. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in GDRZF / Gold Reserve Ltd.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

GDRZF / Gold Reserve Ltd. Insider Trades
Insider Purchases KTTAW / Pasithea Therapeutics Corp. - Equity Warrant - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in GDRZF / Gold Reserve Ltd.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2022-09-29 KTTA Shahinian Eric 6,710 1.1560 336 23.1200 7,757 4 26 954 12.30
2022-09-28 KTTA Shahinian Eric 57,647 1.1890 2,882 23.7800 68,542
2022-09-06 KTTA Shahinian Eric 21,748 1.1326 1,087 22.6520 24,632
2022-09-02 KTTA Shahinian Eric 11,507 1.1389 575 22.7780 13,105
2022-09-01 KTTA Shahinian Eric 55,646 1.1255 2,782 22.5100 62,630
2022-08-30 KTTA Shahinian Eric 17,828 1.1472 891 22.9440 20,452
2022-08-29 KTTA Shahinian Eric 5,000 1.1681 250 23.3620 5,840
2022-08-17 KTTA Shahinian Eric 155,773 1.2087 7,789 24.1740 188,283

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

KTTAW / Pasithea Therapeutics Corp. - Equity Warrant Insider Trades
Insider Sales KTTAW / Pasithea Therapeutics Corp. - Equity Warrant - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in GDRZF / Gold Reserve Ltd.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

KTTAW / Pasithea Therapeutics Corp. - Equity Warrant Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Eric Shahinian as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-04-28 2025-04-24 4 GDRZF GOLD RESERVE LTD
Common Stock
P - Purchase 19,700 9,605,428 0.21 1.60 31,520 15,368,685
2025-04-07 2025-04-07 4 GDRZF GOLD RESERVE LTD
Common Stock
P - Purchase 10,000 9,585,728 0.10 1.68 16,800 16,104,023
2025-04-07 2025-04-04 4 GDRZF GOLD RESERVE LTD
Common Stock
P - Purchase 100 9,575,728 0.00 1.55 155 14,842,378
2025-04-07 2025-04-03 4 GDRZF GOLD RESERVE LTD
Common Stock
P - Purchase 22,375 9,575,628 0.23 1.67 37,366 15,991,299
2025-03-31 2025-03-28 4 GDRZF GOLD RESERVE LTD
Common Stock
P - Purchase 25,000 9,553,253 0.26 1.76 44,000 16,813,725
2025-03-31 2025-03-27 4 GDRZF GOLD RESERVE LTD
Common Stock
P - Purchase 12,000 9,528,253 0.13 1.80 21,600 17,150,855
2025-03-24 2025-03-24 4 GDRZF GOLD RESERVE LTD
Common Stock
P - Purchase 1,500 9,516,253 0.02 1,856.00 2,784,000 17,662,165,568
2025-03-24 2025-03-21 4 GDRZF GOLD RESERVE LTD
Common Stock
P - Purchase 331,900 9,514,753 3.61 2.07 688,593 19,740,258
2025-03-24 2025-03-21 4 GDRZF GOLD RESERVE LTD
Common Stock
P - Purchase 100,000 9,182,853 1.10 2.10 210,000 19,283,991
2025-03-14 2025-03-13 4 GDRZF GOLD RESERVE LTD
Common Stock
P - Purchase 14,000 9,082,853 0.15 2.06 28,840 18,710,677
2025-03-14 2025-03-12 4 GDRZF GOLD RESERVE LTD
Common Stock
P - Purchase 17,154 9,068,853 0.19 2.05 35,166 18,591,149
2025-03-10 2025-03-10 4 GDRZF GOLD RESERVE LTD
Common Stock
P - Purchase 383,401 10,589,030 3.76 1.92 736,130 20,330,938
2025-03-10 2025-03-07 4 GDRZF GOLD RESERVE LTD
Common Stock
P - Purchase 100 10,205,629 0.00 1.70 170 17,349,569
2025-03-10 2025-03-06 4 GDRZF GOLD RESERVE LTD
Common Stock
P - Purchase 27,376 10,205,529 0.27 1.70 46,539 17,349,399
2025-02-06 2025-02-04 4 GDRZF GOLD RESERVE LTD
Common Stock
P - Purchase 100,000 10,178,153 0.99 1.62 162,000 16,488,608
2025-01-23 2025-01-22 4 GDRZF GOLD RESERVE LTD
Common Stock
P - Purchase 56,700 10,078,153 0.57 1.48 83,916 14,915,666
2025-01-14 3 GDRZF GOLD RESERVE LTD
Common Stock
19,073,152
2022-09-30 2022-09-29 4 KTTA Pasithea Therapeutics Corp.
Common Stock
P - Purchase 6,710 1,788,415 0.38 1.16 7,757 2,067,408
2022-09-30 2022-09-28 4 KTTA Pasithea Therapeutics Corp.
Common Stock
P - Purchase 57,647 1,781,705 3.34 1.19 68,542 2,118,447
2022-09-06 2022-09-06 4 KTTA Pasithea Therapeutics Corp.
Common Stock
P - Purchase 21,748 1,724,058 1.28 1.13 24,632 1,952,668
2022-09-06 2022-09-02 4 KTTA Pasithea Therapeutics Corp.
Common Stock
P - Purchase 11,507 1,702,310 0.68 1.14 13,105 1,938,761
2022-09-06 2022-09-01 4 KTTA Pasithea Therapeutics Corp.
Common Stock
P - Purchase 55,646 1,690,803 3.40 1.13 62,630 1,902,999
2022-08-31 2022-08-30 4 KTTA Pasithea Therapeutics Corp.
Common Stock
P - Purchase 17,828 1,635,157 1.10 1.15 20,452 1,875,852
2022-08-31 2022-08-29 4 KTTA Pasithea Therapeutics Corp.
Common Stock
P - Purchase 5,000 1,617,329 0.31 1.17 5,840 1,889,202
2022-08-18 2022-08-17 4 KTTA Pasithea Therapeutics Corp.
Common Stock
P - Purchase 155,773 1,611,329 10.70 1.21 188,283 1,947,613
2022-08-15 3 KTTA Pasithea Therapeutics Corp.
Common Stock
1,455,556
2022-03-16 2022-03-14 4 LSYN Liberated Syndication Inc.
Common Stock
P - Purchase 533,334 5,242,792 11.32 3.75 2,000,002 19,660,470
2022-01-04 2021-12-31 4 LSYN Liberated Syndication Inc.
Common Stock
A - Award 25,000 50,000 100.00
2021-11-29 2021-11-24 4 LSYN Liberated Syndication Inc.
Common stock
P - Purchase 438,791 4,709,458 10.27 3.00 1,316,373 14,128,374
2021-06-07 2021-06-03 4 LSYN Liberated Syndication Inc.
Common stock
P - Purchase 2,133,334 4,270,667 99.81 3.75 8,000,002 16,015,001
2020-12-07 2020-12-03 4 LSYN Liberated Syndication Inc.
Common Stock
P - Purchase 8,534 2,137,333 0.40 3.80 32,420 8,119,514
2020-12-03 2020-12-02 4 LSYN Liberated Syndication Inc.
Common stock
P - Purchase 35,050 2,128,799 1.67 3.74 131,182 7,967,456
2020-12-03 2020-12-01 4 LSYN Liberated Syndication Inc.
Common stock
P - Purchase 25,133 2,093,749 1.21 3.71 93,359 7,777,440
2020-09-08 2020-09-04 4 LSYN Liberated Syndication Inc.
Common Stock
P - Purchase 1,600 2,068,616 0.08 3.62 5,786 7,480,736
2020-09-08 2020-09-03 4 LSYN Liberated Syndication Inc.
Common Stock
P - Purchase 13,892 2,067,016 0.68 3.67 50,938 7,579,128
2020-02-20 2020-02-18 4 LSYN Liberated Syndication Inc.
Common stock
A - Award 25,000 25,000
2019-12-10 2019-12-09 4 LSYN Liberated Syndication Inc.
Common stock
P - Purchase 5,500 2,053,124 0.27 3.20 17,600 6,569,997
2019-12-10 2019-12-06 4 LSYN Liberated Syndication Inc.
Common stock
P - Purchase 63,800 2,047,624 3.22 3.20 204,141 6,551,783
2019-12-06 2019-12-05 4 LSYN Liberated Syndication Inc.
Common Stock
P - Purchase 7,039 1,983,824 0.36 3.15 22,173 6,249,046
2019-12-06 2019-12-04 4 LSYN Liberated Syndication Inc.
Common Stock
P - Purchase 1,466 1,976,785 0.07 3.15 4,618 6,226,873
2019-12-04 2019-12-02 4 LSYN Liberated Syndication Inc.
Common Stock
P - Purchase 9,000 1,975,319 0.46 3.14 28,282 6,207,242
2019-11-27 2019-11-26 4 LSYN Liberated Syndication Inc.
Common stock
P - Purchase 3,000 1,966,319 0.15 2.96 8,870 5,813,815
2019-11-27 2019-11-25 4 LSYN Liberated Syndication Inc.
Common stock
P - Purchase 7,800 1,963,319 0.40 2.98 23,251 5,852,458
2019-10-10 3 LSYN Liberated Syndication Inc.
Common stock, par value $0.0001 per share
3,911,038
2019-10-10 3 LSYN Liberated Syndication Inc.
Common stock, par value $0.0001 per share
3,911,038
2019-10-10 3 LSYN Liberated Syndication Inc.
Common stock, par value $0.0001 per share
3,911,038
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)